{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T02:15:05Z","timestamp":1784081705858,"version":"3.55.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Hong Kong Research Grant Council","award":["GRF17122915"],"award-info":[{"award-number":["GRF17122915"]}]},{"name":"Hong Kong Research Grant Council","award":["HKU5\/CRF\/13G"],"award-info":[{"award-number":["HKU5\/CRF\/13G"]}]},{"name":"Hong Kong Research Grant Council","award":["A-HKU709\/14"],"award-info":[{"award-number":["A-HKU709\/14"]}]},{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"crossref","award":["13121272"],"award-info":[{"award-number":["13121272"]}],"id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012151","name":"San-Ming Project of Medicine in Shenzhen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.vaccine.2018.06.047","type":"journal-article","created":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T13:33:49Z","timestamp":1530192829000},"page":"4621-4632","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["DNA prime\/MVTT boost regimen with HIV-1 mosaic Gag enhances the potency of antigen-specific immune responses"],"prefix":"10.1016","volume":"36","author":[{"given":"Wan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yik Chun","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha M.Y.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiansong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen Ka Loon","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7213","key":"10.1016\/j.vaccine.2018.06.047_b0005","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/455609a","article-title":"The changing face of HIV in China","volume":"455","author":"Lu","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2018.06.047_b0010","doi-asserted-by":"crossref","DOI":"10.1099\/jgv.0.000706","article-title":"Isolation and characterization of HIV-1 envelope glycoprotein specific B cell from immortalized human naive B cell library","author":"Sun","year":"2017","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2018.06.047_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2015.02.006","article-title":"Reconstitution and characterization of antibody repertoires of HIV-1-infected \u201celite neutralizers\u201d","volume":"118","author":"Sun","year":"2015","journal-title":"Antivir Res"},{"issue":"5","key":"10.1016\/j.vaccine.2018.06.047_b0020","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jinf.2010.03.005","article-title":"Induction of balance and breadth in the immune response is beneficial for the control of SIVmac239 replication in rhesus monkeys","volume":"60","author":"Sun","year":"2010","journal-title":"J Infect"},{"issue":"23","key":"10.1016\/j.vaccine.2018.06.047_b0025","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand","volume":"361","author":"Rerks-Ngarm","year":"2009","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2018.06.047_b0030","doi-asserted-by":"crossref","first-page":"e4180","DOI":"10.1371\/journal.pone.0004180","article-title":"A novel replication-competent vaccinia vector MVTT is superior to MVA for inducing high levels of neutralizing antibody via mucosal vaccination","volume":"4","author":"Huang","year":"2009","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.vaccine.2018.06.047_b0035","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/jmv.21667","article-title":"The route of inoculation determines the tissue tropism of modified vaccinia Tiantan expressing the spike glycoprotein of SARS-CoV in mice","volume":"82","author":"Liu","year":"2010","journal-title":"J Med Virol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2018.06.047_b0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jviromet.2007.03.012","article-title":"The attenuation of vaccinia Tian Tan strain by the removal of the viral M1L\u2013K2L genes","volume":"144","author":"Zhu","year":"2007","journal-title":"J Virol Methods"},{"issue":"2","key":"10.1016\/j.vaccine.2018.06.047_b0045","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.virol.2005.02.014","article-title":"Host range, growth property, and virulence of the smallpox vaccine: vaccinia virus Tian Tan strain","volume":"335","author":"Fang","year":"2005","journal-title":"Virology"},{"issue":"9","key":"10.1016\/j.vaccine.2018.06.047_b0050","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.vaccine.2009.12.038","article-title":"One time intranasal vaccination with a modified vaccinia Tiantan strain MVTT(ZCI) protects animals against pathogenic viral challenge","volume":"28","author":"Yu","year":"2010","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2018.06.047_b0055","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2013.09.061","article-title":"Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys","volume":"155","author":"Barouch","year":"2013","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.vaccine.2018.06.047_b0060","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1172\/JCI64704","article-title":"PD1-based DNA vaccine amplifies HIV-1 GAG-specific CD8+ T cells in mice","volume":"123","author":"Zhou","year":"2013","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.vaccine.2018.06.047_b0065","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nm.f.1759","article-title":"Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans","volume":"14","author":"Watkins","year":"2008","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.vaccine.2018.06.047_b0070","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2174\/1566524033479807","article-title":"Cellular immunity for prevention and clearance of HIV infection","volume":"3","author":"Kalams","year":"2003","journal-title":"Curr Mol Med"},{"issue":"5","key":"10.1016\/j.vaccine.2018.06.047_b0075","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1128\/JVI.02256-08","article-title":"Expanded breadth of the T-cell response to mosaic human immunodeficiency virus type 1 envelope DNA vaccination","volume":"83","author":"Kong","year":"2009","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2018.06.047_b0080","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nm1461","article-title":"Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants","volume":"13","author":"Fischer","year":"2007","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.vaccine.2018.06.047_b0085","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.cell.2013.10.012","article-title":"First steps toward a globally effective HIV\/AIDS vaccine","volume":"155","author":"Palesch","year":"2013","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.vaccine.2018.06.047_b0090","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nm1520","article-title":"CD8+ T-cell responses to different HIV proteins have discordant associations with viral load","volume":"13","author":"Kiepiela","year":"2007","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.vaccine.2018.06.047_b0095","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/infdis\/jiq119","article-title":"The STEP study provides a hint that vaccine induction of the right CD8+ T cell responses can facilitate immune control of HIV","volume":"203","author":"Altfeld","year":"2011","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2018.06.047_b0100","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nrg2432","article-title":"DNA vaccines: ready for prime time?","volume":"9","author":"Kutzler","year":"2008","journal-title":"Nat Rev Genet"},{"issue":"21","key":"10.1016\/j.vaccine.2018.06.047_b0105","doi-asserted-by":"crossref","first-page":"6010","DOI":"10.1158\/0008-5472.CAN-14-0473","article-title":"Vaccine-elicited CD8+ T cells cure mesothelioma by overcoming tumor-induced immunosuppressive environment","volume":"74","author":"Tan","year":"2014","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.vaccine.2018.06.047_b0110","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1006\/viro.1997.8845","article-title":"Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line","volume":"238","author":"Carroll","year":"1997","journal-title":"Virology"},{"issue":"10","key":"10.1016\/j.vaccine.2018.06.047_b0115","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1073\/pnas.0500649102","article-title":"A mouse model for study of systemic HIV-1 infection, antiviral immune responses, and neuroinvasiveness","volume":"102","author":"Potash","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2018.06.047_b0120","doi-asserted-by":"crossref","DOI":"10.1007\/s11481-016-9654-0","article-title":"Brain invasion by CD4 T cells infected with a transmitted\/founder HIV-1 during acute stage in humanized mice","author":"Wu","year":"2016","journal-title":"J Neuroimmune Pharmacol"},{"issue":"3","key":"10.1016\/j.vaccine.2018.06.047_b0125","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nm.2089","article-title":"Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys","volume":"16","author":"Barouch","year":"2010","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.vaccine.2018.06.047_b0130","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nm.2108","article-title":"Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys","volume":"16","author":"Santra","year":"2010","journal-title":"Nat Med"},{"issue":"27","key":"10.1016\/j.vaccine.2018.06.047_b0135","doi-asserted-by":"crossref","first-page":"5102","DOI":"10.1016\/j.vaccine.2006.09.071","article-title":"Immunogenicity of recombinant human immunodeficiency virus type 1-like particles expressing gp41 derivatives in a pre-fusion state","volume":"25","author":"Kim","year":"2007","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2018.06.047_b0140","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.4049\/jimmunol.1004110","article-title":"Early induction of polyfunctional simian immunodeficiency virus (SIV)-specific T lymphocytes and rapid disappearance of SIV from lymph nodes of sooty mangabeys during primary infection","volume":"186","author":"Meythaler","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.06.047_b0145","doi-asserted-by":"crossref","unstructured":"yuzhe, Antigen spreading-induced CD8+T cells confer protection against the lethal challenge of wild-type malignant mesothelioma by eliminating myeloid-derived suppressor cells; 2015.","DOI":"10.18632\/oncotarget.5856"},{"issue":"52","key":"10.1016\/j.vaccine.2018.06.047_b0150","doi-asserted-by":"crossref","first-page":"8660","DOI":"10.1016\/j.vaccine.2007.10.019","article-title":"Vaccine-induced protection from infection of mice by chimeric human immunodeficiency virus type 1, EcoHIV\/NL4-3","volume":"25","author":"Saini","year":"2007","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2018.06.047_b0155","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/nm1492","article-title":"Interleukin-10 determines viral clearance or persistence in vivo","volume":"12","author":"Brooks","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2018.06.047_b0160","doi-asserted-by":"crossref","first-page":"564","DOI":"10.3389\/fimmu.2016.00564","article-title":"Type I interferon impairs specific antibody responses early during establishment of LCMV infection","volume":"7","author":"Daugan","year":"2016","journal-title":"Front Immunol"},{"issue":"6831","key":"10.1016\/j.vaccine.2018.06.047_b0165","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/35073658","article-title":"Cellular immune responses to HIV","volume":"410","author":"McMichael","year":"2001","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.vaccine.2018.06.047_b0170","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ni845","article-title":"HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors","volume":"3","author":"Migueles","year":"2002","journal-title":"Nat Immunol"},{"issue":"22","key":"10.1016\/j.vaccine.2018.06.047_b0175","doi-asserted-by":"crossref","first-page":"12638","DOI":"10.1128\/JVI.78.22.12638-12646.2004","article-title":"Human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cells that proliferate in vitro detected in samples from most viremic subjects and inversely associated with plasma HIV-1 levels","volume":"78","author":"Boritz","year":"2004","journal-title":"J Virol"},{"issue":"5342","key":"10.1016\/j.vaccine.2018.06.047_b0180","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1126\/science.278.5342.1447","article-title":"Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia","volume":"278","author":"Rosenberg","year":"1997","journal-title":"Science"},{"issue":"24","key":"10.1016\/j.vaccine.2018.06.047_b0185","doi-asserted-by":"crossref","first-page":"13456","DOI":"10.1128\/JVI.01619-07","article-title":"Dynamics of T-cell responses and memory T cells during primary simian immunodeficiency virus infection in cynomolgus macaques","volume":"81","author":"Karlsson","year":"2007","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2018.06.047_b0190","doi-asserted-by":"crossref","first-page":"e55831","DOI":"10.1371\/journal.pone.0055831","article-title":"Safety and immunogenicity of DNA and MVA HIV-1 subtype C vaccine prime-boost regimens: a phase I randomised Trial in HIV-uninfected Indian volunteers","volume":"8","author":"Mehendale","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.vaccine.2018.06.047_b0195","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.coi.2009.05.016","article-title":"Heterologous prime-boost vaccination","volume":"21","author":"Lu","year":"2009","journal-title":"Curr Opin Immunol"},{"issue":"18","key":"10.1016\/j.vaccine.2018.06.047_b0200","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1097\/QAD.0b013e328010ad0c","article-title":"Sequential priming and boosting with heterologous HIV immunogens predominantly stimulated T cell immunity against conserved epitopes","volume":"20","author":"Xu","year":"2006","journal-title":"Aids"},{"issue":"4","key":"10.1016\/j.vaccine.2018.06.047_b0205","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/infdis\/jiv496","article-title":"Vaccination with heterologous HIV-1 envelope sequences and heterologous adenovirus vectors increases T-cell responses to conserved regions: HVTN 083","volume":"213","author":"Walsh","year":"2016","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2018.06.047_b0210","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1586\/erv.10.106","article-title":"Prime-boost immunization with poxvirus or adenovirus vectors as a strategy to develop a protective vaccine for HIV-1","volume":"9","author":"Paris","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2018.06.047_b0215","doi-asserted-by":"crossref","first-page":"14006","DOI":"10.1038\/mto.2014.6","article-title":"Overcoming tumor resistance by heterologous adeno-poxvirus combination therapy","volume":"1","author":"Vaha-Koskela","year":"2015","journal-title":"Mol Ther Oncolytics"},{"issue":"1","key":"10.1016\/j.vaccine.2018.06.047_b0220","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/s12967-016-1102-7","article-title":"Increased T cell breadth and antibody response elicited in prime-boost regimen by viral vector encoded homologous SIV Gag\/Env in outbred CD1 mice","volume":"14","author":"Andersson","year":"2016","journal-title":"J Transl Med"},{"key":"10.1016\/j.vaccine.2018.06.047_b0225","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1479-5876-8-132","article-title":"Programmed cell death-1 (PD-1) at the heart of heterologous prime-boost vaccines and regulation of CD8+ T cell immunity","volume":"8","author":"Bot","year":"2010","journal-title":"J Transl Med"},{"issue":"4","key":"10.1016\/j.vaccine.2018.06.047_b0230","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.cell.2015.01.027","article-title":"Manipulating the selection forces during affinity maturation to generate cross-reactive HIV antibodies","volume":"160","author":"Wang","year":"2015","journal-title":"Cell"},{"issue":"32","key":"10.1016\/j.vaccine.2018.06.047_b0235","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.1016\/j.vaccine.2016.05.030","article-title":"A polyvalent influenza DNA vaccine applied by needle-free intradermal delivery induces cross-reactive humoral and cellular immune responses in pigs","volume":"34","author":"Borggren","year":"2016","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2018.06.047_b0240","doi-asserted-by":"crossref","first-page":"e1000480","DOI":"10.1371\/journal.ppat.1000480","article-title":"Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome","volume":"5","author":"Delaloye","year":"2009","journal-title":"PLoS Pathog"},{"issue":"48","key":"10.1016\/j.vaccine.2018.06.047_b0245","doi-asserted-by":"crossref","first-page":"20382","DOI":"10.1073\/pnas.0911742106","article-title":"HIV-1 Gag-specific immunity induced by a lentivector-based vaccine directed to dendritic cells","volume":"106","author":"Dai","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.vaccine.2018.06.047_b0250","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.4049\/jimmunol.180.4.2504","article-title":"Novel vaccination protocol with two live mucosal vectors elicits strong cell-mediated immunity in the vagina and protects against vaginal virus challenge","volume":"180","author":"Li","year":"2008","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2018.06.047_b0255","doi-asserted-by":"crossref","first-page":"5669","DOI":"10.1128\/JVI.03247-12","article-title":"Mucosal priming with a replicating-vaccinia virus-based vaccine elicits protective immunity to simian immunodeficiency virus challenge in rhesus monkeys","volume":"87","author":"Sun","year":"2013","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2018.06.047_b0260","doi-asserted-by":"crossref","first-page":"a007351","DOI":"10.1101\/cshperspect.a007351","article-title":"Human immunodeficiency virus vaccine trials","volume":"2","author":"O'Connell","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"6274","key":"10.1016\/j.vaccine.2018.06.047_b0265","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1126\/science.aac9475","article-title":"Broadly targeted CD8(+) T cell responses restricted by major histocompatibility complex E","volume":"351","author":"Hansen","year":"2016","journal-title":"Science"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18308880?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18308880?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:26:22Z","timestamp":1759400782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18308880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":53,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0264410X18308880"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.06.047","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DNA prime\/MVTT boost regimen with HIV-1 mosaic Gag enhances the potency of antigen-specific immune responses","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.06.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}